Stock listing
NASDAQ:LOXO Loxo Oncology Inc Stock
Follow Loxo Oncology Inc into a list and get an email when it puts out news.
Last close · NASDAQ:LOXO
$234.66 USD
Close on Feb 15, 2019 · No longer trades
- Lowest – highest close
- $10.01 – $234.75 USDSince Aug 1, 2014 · lowest Dec 1, 2014 · highest Feb 5, 2019
Delisted NASDAQ:LOXO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LOXO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Loxo Oncology Inc on 6ix
- Decks
- 7 decks · latest Jan 8, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2018) | Investor deck | 45 slides | Jan 8, 2018 |
| Corporate Update (June 2017) | Corporate update | 32 slides | Jun 5, 2017 |
| 2017 ASCO Annual Meeting | Conference | 24 slides | Jun 5, 2017 |
| Technical Presentation (December 2016) | Technical | 13 slides | Dec 19, 2016 |
| Corporate Update (December 2016) | Corporate update | 42 slides | Dec 19, 2016 |
| Technical Presentation (April 2016) | Technical | 32 slides | Apr 18, 2016 |
| Technical Presentation (November 2015) | Technical | 19 slides | Nov 9, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dov Goldstein Other companies: BioAge Labs, Inc. (Chief Financial Officer · Since at least Sep 25, 2024); Coya Therapeutics, Inc. (Director · Since at least Dec 28, 2022); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past) | CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past |
| Lori Kunkel Other companies: Enliven Therapeutics, Inc. (Director · Since at least Apr 8, 2024); ORIC Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2020); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 19, 2025 · Past); Tocagen Inc (Director · Jun 21, 2018 – Oct 4, 2019 · Past); Curis, Inc. (Director · Jan 22, 2018 – Jan 31, 2022 · Past) | Director · Nov 2, 2017 – Feb 15, 2019 · Past |
| Timothy M Mayleben Other companies: Landos Biopharma Inc (Director · May 13, 2021 – May 23, 2024 · Past); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Feb 7, 2025 · Past); Esperion Therapeutics, Inc. (President & CEO, Director · Jun 25, 2013 – Jan 28, 2021 · Past); Vericel Corporation (President and CEO, Director · Oct 17, 2008 – Aug 29, 2012 · Past) | Director · Jul 28, 2015 – Feb 15, 2019 · Past |
| Jennifer Burstein Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019) | Senior VP of Finance · May 1, 2015 – Feb 15, 2019 · Past |
| Jennifer A Low | Chief Medical Officer · Jul 31, 2014 – Dec 19, 2014 · Past |
Log in to ask 6ix AI your own questions about Loxo Oncology Inc.